Integral Derivatives’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,846
Closed -$200K 1141
2017
Q1
$201K Buy
+7,846
New +$200K ﹤0.01% 1022
2016
Q1
Sell
-17,343
Closed -$344K 928
2015
Q4
$344K Buy
17,343
+7,150
+70% +$145K 0.01% 762
2015
Q3
$216K Buy
+10,193
New +$229K 0.01% 957
2014
Q3
Sell
-39,342
Closed -$921K 1432
2014
Q2
$1.02M Sell
39,342
-4,065
-9% -$104K 0.02% 677
2014
Q1
$1.04M Sell
43,407
-28,321
-39% -$596K 0.02% 640
2013
Q4
$1.4M Buy
+71,728
New +$1.44M 0.02% 651

Other funds holding EXC

Integral Derivatives's EXC Position: Q2 2017 in Review

Integral Derivatives sold out of Exelon (EXC) in Q2 2017, closing a stake of 7,846 shares — an estimated $200K sold.

Integral Derivatives first reported a position in EXC in Q4 2013 and held it in 6 quarters. The position peaked at $1.4M in Q4 2013. 793 funds tracked by Wall St. Rank hold EXC as of Q2 2017.

  • Integral Derivatives reported no remaining Exelon position as of Q2 2017 after selling out during the quarter.
  • Integral Derivatives sold 7,846 Exelon shares in Q2 2017, an estimated $200K.
  • Integral Derivatives first reported a position in Exelon in Q4 2013 and held it in 6 quarters.
  • Integral Derivatives's Exelon position peaked at $1.4M in Q4 2013.
  • 793 funds tracked by Wall St. Rank held Exelon as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.